Abstract

BackgroundPhenylketonuria (PKU) is an autosomal recessive disease resulting from mutations in the PAH gene. Most of the patients are compound heterozygotes, and genotype is a major factor in determining the phenotypic variability of PKU. More than 1,000 variants have been described in the PAH gene. Rio de Janeiro's population has a predominance of Iberian, followed by African and Amerindian ancestries. It is expected that most PKU variants in this Brazilian state have originated in the Iberian Peninsula. However, rare European, African or pathogenic variants that are characteristic of the admixed population of the state might also be found.MethodsA total of 102 patients were included in this study. Genomic DNA was isolated from dried blood spots. Sanger sequencing was used for PAH gene variant identification. Deletions and duplications were also screened using MLPA analysis. Haplotypes were also determined.ResultsNine (8.8%) homozygous and 93 (91.2%) compound heterozygous patients were found. The spectrum included 37 causative mutations. Missense, nonsense, and splicing pathogenic variants corresponded to 63.7%, 2.9%, and 22.6% of the mutant alleles, respectively. Large (1.5%), and small deletions, inframe (5.4%) and with frameshift (3.9%), comprised the remainder. The most frequent pathogenic variants were: p.V388M (12.7%), p.R261Q (11.8%), IVS10‐11G>A (10.3%), IVS2+5G>C (6.4%), p.S349P (6.4%), p.R252W (5.4%), p.I65T (4.4%), p.T323del (4.4%), and p.P281L (3.4%). One novel variant was detected: c.934G>T (p.G312C) [rs763115697].ConclusionThe three most frequent pathogenic variants in our study (34.8% of the alleles) were also the most common in other Brazilian states, Portugal, and Spain (p.V388M, p.R261Q, IVS10‐11G>A), corroborating that the Iberian Peninsula is the major source of PAH mutations in Rio de Janeiro. Pathogenic variants that have other geographical origins, such IVS2+5G>C, p.G352Vfs*48, and IVS12+1G>A were also detected. Genetic drift and founder effect may have also played a role in the mutation spectrum we observed.

Highlights

  • Phenylketonuria (PKU; OMIM # 261600) is a hereditary autosomal recessive disease characterized by an accumulation of the amino acid phenylalanine (Phe) in blood and other tissues (Donlon, Sarkissian, Levy, & Scriver, 2014)

  • 1041, of which circa 630 are disease-causing mutations, associated with various degrees of PAH deficiency (BIOPKU; http://www.biopku.org/biopku/search-start.asp). These mutations may result in clinical manifestations ranging from mild hyperphenylalaninemia (MHP), which does not require dietary therapy, to a severe and persistent phenotype, classic PKU (Guldberg et al, 1998)

  • The analysis revealed that approximately 16 different haplotypes were associated with the mutant alleles (Table 2)

Read more

Summary

| INTRODUCTION

Phenylketonuria (PKU; OMIM # 261600) is a hereditary autosomal recessive disease characterized by an accumulation of the amino acid phenylalanine (Phe) in blood (hyperphenylalaninemia) and other tissues (Donlon, Sarkissian, Levy, & Scriver, 2014). The polymorphic sites are in linkage disequilibrium and describe a large series of extended and mini-haplotypes These haplotypes have been extensively used as tools in population genetics studies to increase the knowledge of the historical and prehistorical movements of human populations, which can explain the contemporary geographic distribution of many PAH gene mutant alleles (Rivera et al, 2011). In the 60s of the 20th century, Guthrie developed a bacterial inhibition test that could detect high amounts of Phe in a dried blood spot (Guthrie & Susi, 1963) This test made it possible to carry out newborn screening test for PKU, enabling early diagnosis and dietary treatment of the disease and the prevention of the development of intellectual disability (van Wegberg et al, 2017). This study seeks to produce knowledge that will contribute to settle these issues

| Ethical compliance
| RESULTS
| DISCUSSION
Findings
DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call